Disclosure 0000200406-26-000175-2

SEC FORM 4

$3,950,400.00

JOHNSON & JOHNSON (JNJ)

Sale of 15,000 shares at $263.36 per share.

Reporting Person Taubert Jennifer L · Officer Title EVP, WWC. Innovative Medicine · Transaction Code S

Traded Aug 17, 2026 · Disclosed Aug 18, 2026

Source: SEC Form 4 · 0000200406-26-000175 · filed 2026-08-18 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "JOHNSON & JOHNSON (JNJ)." Disclosed 2026-08-18. https://desqlong.com/cards/0000200406-26-000175-2 (retrieved 2026-09-26).